The Screen · Technology · Software - Infrastructure
CrowdStrike
CRWD · a US exchange · USD · Market cap $215.0B · 10,698 employees
CrowdStrike Holdings, Inc.
FAIL · Does not pass the screen
210.02 USD
At the last full screen 2026-09-08
Screened 2026-09-08 · the tape above runs as of 22:12 UTC · 11 Sep · two dates, stated on purpose · verdict and workings shown in full · never trimmed
The Label · The Season, Not the Day
This name holds its distribution label.
CrowdStrike holds its Distribution at $210.02. The statistical read favours the sellers, held for 7 days.
As held on the ledger · 2026-09-08
Phase
Distribution · caution
Quantitative state
The statistical read favours the sellers, held for 7 days
Price at the screen
$210.02
Valuation
5,250.50 trailing · 130.89 forward price to earnings
Values screen
FAIL· score 70.0
Beta
1.26
The Workings
Five Screens, Shown in Full
Does not pass. Accounts receivable
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
7.40%
Below 33%
Interest-bearing debt is just 7.4% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
0.69%
Below 33%
Cash held in interest-bearing accounts and securities is 0.7% of assets, under the one-third limit.
Pass
Receivables
59.46%
Below 49%
Money owed to the company is 59.5% of assets, above the 49% limit.
Fail
Revenue purity
4.05%
Below 5%
Only 4.1% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is Worth
The Fair Value Range
Our framework reads AVOID: it trades above our $140.86 fair value estimate, weak competitive moat, 25.80% revenue growth.
Fair value range in USD, drawn from the 2026-09-08 screen. The gold marker is the market price at the same screen. The price runs 32.9% above the base estimate.
Third-party analyst targets: 50 covering, consensus Buy. The average target sits +14% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-08 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Cloud Security Giant Fails Ethical Standards
Imagine a world where every digital footstep is a target for cyber threats; CrowdStrike stands as a fortress, protecting businesses with its cybersecurity solutions. However, for all its technological prowess, CrowdStrike fails to meet our ethical standards, specifically in managing accounts receivable, leading to a FAIL on our ethical screen.
Despite presenting an impressive 26% revenue growth and a forward P/E of 121.4x, CrowdStrike's profitability remains elusive with a profit margin of -1% and a return on equity (ROE) of 0%. This financial performance, coupled with a weak moat and a stock price well above our fair value of $125.94, raises concerns about the investment's sustainability and the margin of safety.
The consensus rating from 50 analysts is a buy, with a median target price of $211. However, given the ethical failings and the current valuation, we advise caution. The risks are significant, especially considering the ethical dimension, which is non-negotiable from our perspective. Analysis, not advice.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
CRWD trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-08-26Markup$190.34+0.0%Entry 12
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are up 39%. Our forward projection puts the odds of a 10% gain over the next month near 34%. The street (51 analysts) rates it buy, with a mean price target of $535. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-25Markup$190.34+0.0%Entry 11
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are up 39%. Our forward projection puts the odds of a 10% gain over the next month near 34%. The street (51 analysts) rates it buy, with a mean price target of $535. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-24Markup$190.34+0.0%Entry 10
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are up 39%. Our forward projection puts the odds of a 10% gain over the next month near 34%. The street (51 analysts) rates it buy, with a mean price target of $535. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-23Markup$190.34+0.0%Entry 9
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are up 39%. Our forward projection puts the odds of a 10% gain over the next month near 34%. The street (51 analysts) rates it buy, with a mean price target of $535. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-22Markup$190.34+0.0%Entry 8
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are up 39%. Our forward projection puts the odds of a 10% gain over the next month near 34%. The street (51 analysts) rates it buy, with a mean price target of $535. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-21Markup$190.34-9.3%Entry 7
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 9.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are up 39%. Our forward projection puts the odds of a 10% gain over the next month near 34%. The street (51 analysts) rates it buy, with a mean price target of $535. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-20Markup$209.86+0.0%Entry 6
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are up 39%. Our forward projection puts the odds of a 10% gain over the next month near 34%. The street (51 analysts) rates it buy, with a mean price target of $535. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-19Markup · changed$209.86+14.5%Entry 5
The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 14.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are up 39%. Our forward projection puts the odds of a 10% gain over the next month near 34%. The street (51 analysts) rates it buy, with a mean price target of $535. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-25Accumulation$183.28-72.7%Entry 4
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 72.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are up 39%. Our forward projection puts the odds of a 10% gain over the next month near 34%. The street (51 analysts) rates it buy, with a mean price target of $535. Insiders have been net sellers over the past quarter.
2026-07-18Accumulation$671.02+0.0%Entry 3
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are up 39%. Our forward projection puts the odds of a 10% gain over the next month near 34%. The street (51 analysts) rates it buy, with a mean price target of $535. Insiders have been net sellers over the past quarter.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
